Amarin Corp Plc (AMRN)

[ORBAPU]

FYI for those who have or know someone with AMD. MADEOS trial showed regression in 6 months using a formulation of 2928 mg EPA / 732 mg DHA. Small study (pilot) yet achieved statistical significance. AA/EPA levels were measured. Odd that this hasn't received more visibility and we have a drug, Vascepa, ready to go. 
https://www.sciencedirect.com/science/article/pii/S2213434424000264?ref=pdf_download&fr=RR-2&rr=985c8686e9a351ee

https://eyetas.com/ophthalmos-institute-reports-positive-efficacy-data-from-the-madeos-study-on-dry-macular-degeneration-and-stargardt-disease-publications/

https://touchophthalmology.com/macular-degeneration/conference-hub/28076/